How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
Pio Conti 1, Gallenga CE2, Tetè G3, Caraffa A4, Ronconi G5, Younes A6, Toniato E7, Ross R8, Kritas...
Category: Pio Conti
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (CoV-19 or SARS-CoV-2): anti-inflammatory strategies.
Authors: Pio Conti 1, Ronconi G2, Caraffa A3, Gallenga CE4,...
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.
Kritas SK1, Ronconi G2, Caraffa A3, Gallenga CE4, Ross R5, Pio Conti 6. Author...
CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37.
Caraffa Al1, Gallenga CE2, Kritas SK3, Ronconi G4, Di Emidio P5, Pio Conti 6....
Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity.
Franza L1,2, Carusi V1,2, Altamura S1,2, Caraffa A3, Gallenga CE4, Kritas SK5, Ronconi G6, Pio Conti...
Mesenchymal stem cells and IL-37: a powerful combination.
Gugliandolo A1, Caraffa AL2, Gallenga CE3, Kritas SK4, Ronconi G5, Trubiani O6, Pio Conti 7, Di...
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited?
Caraffa A1, Gallenga CE2, Kritas SK3, Ronconi G4, Pio Conti 5. Author information...
Interleukin-1 family cytokines and mast cells: activation and inhibition.
Gallenga CE1, Pandolfi F2, Caraffa A3, Kritas SK4, Ronconi G5, Toniato E6, Martinotti S6, Pio Conti...
Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G1, Tettamanti L2, Gallenga CE3, Caraffa A4, D’Ovidio C5, Mastrangelo F6, Ronconi G7, Kritas SK8, Pio...
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
Tettamanti L1, Kritas SK2, Gallenga CE3, D’Ovidio C4, Mastrangelo F5, Ronconi G6, Caraffa A7, Toniato E8, Pio...
